Ligne de temps

Pierre Bruhns
Responsable de Structure
10 Jul 2019
publication

An IgG-induced neutrophil activation pathway contributes to human drug-induced anaphylaxis

Lire plus
14 Feb 2019
team

Immunité Humorale

Lire plus
14 Jan 2019
event

Antibodies and Complement conference

Lire plus
07 Nov 2018
project

High throughput selection of nanobodies by droplet based microfluidics (PTR nanofluidic)

Lire plus
04 Jun 2018
event

Cellular stress and control of inflammation in autoimmune disease and cancer

Lire plus
13 Apr 2018
publication

Platelets expressing IgG receptor FcγRIIA/CD32A determine the severity of experimental anaphylaxis.

Lire plus
20 Oct 2017
publication

Low end-tidal CO2 as a real-time severity marker of intra-anaesthetic acute hypersensitivity reactions.

Lire plus
11 Sep 2017
publication

Single-cell deep phenotyping of IgG-secreting cells for high-resolution immune monitoring

Lire plus
17 Feb 2017
publication

Neutrophil myeloperoxidase diminishes the toxic effects and mortality induced by lipopolysaccharide

Lire plus
10 Oct 2016
publication

In vivo effector functions of high-affinity mouse IgG receptor FcγRI in disease and therapy models.

Lire plus
24 Aug 2016
publication

Mechanisms of anaphylaxis in human low-affinity IgG receptor locus knock-in mice.

Lire plus
26 Apr 2016
publication

IgG subclasses determine pathways of anaphylaxis in mice.

Lire plus
27 Oct 2015
project

Microfluidics@Pasteur

Lire plus
26 Oct 2015
publication

Mouse and human FcR effector functions.

Lire plus
22 Oct 2015
project

ERC-2013-CoG – 616050_MyeloSHOCK – Role of myeloid cells, their mediators and their antibody receptors in allergic shock (anaphylaxis) using humanized mouse models and clinical samples

Lire plus
21 Oct 2015
project

DROPmAbs – Deep-mining of antibody repertoires using droplet-based microfluidics combined with barcoded deep sequencing for diagnostics and therapeutic antibody discovery

Lire plus
20 Oct 2015
project

Role of platelets and their interactions in allergic diseases

Lire plus
19 Oct 2015
project

Clinical and pathological consequences of human anti-drug antibodies (NASA study)

Lire plus
18 Oct 2015
project

Developing novel models of disease and vaccination in Ab- and FcR-humanized mice

Lire plus
17 Oct 2015
project

Antibody-based anti-tumor immunotherapy

Lire plus
01 Sep 2015
patent

METHODS FOR INHIBITING MAST CELL ACTIVATION AND TREATING MAST CELL-DEPENDENT INFLAMMATORY DISEASES AND DISORDERS USING LACTOBACILLUS

Lire plus
01 Sep 2015
patent

USE OF ANTl-FcyRI AND/OR ANTl-FcyRllA ANTIBODIES FOR TREATING ARTHRITIS, INFLAMMATION, THROMBOCYTOPENIA AND ALLERGIC SHOCK

Lire plus
27 May 2015
publication

Shaping mycolactone for therapeutic use against inflammatory disorders

Lire plus
11 May 2015
team

Anticorps en Thérapie et Pathologie

Lire plus
17 Oct 2014
publication

Intravenous immunoglobulin promotes antitumor responses by modulating macrophage polarization

Lire plus
30 Jul 2014
publication

A FcγRIII-engaging bispecific antibody expands the range of HER2-expressing breast tumors eligible to antibody therapy

Lire plus
25 Jul 2014
publication

Shifting FcγRIIA-ITAM from activation to inhibitory configuration ameliorates arthritis

Lire plus
30 May 2014
publication

Contribution of Human FcγRs to Disease with Evidence from Human Polymorphisms and Transgenic Animal Studies

Lire plus
21 Jan 2014
publication

The function of Fcγ receptors in dendritic cells and macrophages

Lire plus
26 Aug 2013
publication

Neutrophils mediate antibody-induced antitumor effects in mice

Lire plus
26 Mar 2013
publication

Neutrophils in local and systemic antibody-dependent inflammatory and anaphylactic reactions

Lire plus
04 Jan 2013
publication

The high-affinity human IgG receptor FcγRI (CD64) promotes IgG-mediated inflammation, anaphylaxis, and antitumor immunotherapy

Lire plus
03 Dec 2012
publication

Quorum sensing contributes to activated IgM-secreting B cell homeostasis

Lire plus
12 Nov 2012
publication

Cutting edge: FcγRIII (CD16) and FcγRI (CD64) are responsible for anti-glycoprotein 75 monoclonal antibody TA99 therapy for experimental metastatic B16 melanoma

Lire plus
01 Sep 2012
publication

A hypomorphic mutation in the Gfi1 transcriptional repressor results in a novel form of neutropenia

Lire plus
20 Aug 2012
publication

Autonomous phagosomal degradation and antigen presentation in dendritic cells

Lire plus
30 Jul 2012
publication

Apoptosis of mouse mast cells is reciprocally regulated by the IgG receptors FcγRIIB and FcγRIIIA

Lire plus
25 Apr 2012
publication

Properties of mouse and human IgG receptors and their contribution to disease models

Lire plus
02 Dec 2011
publication

Human FcγRIIA induces anaphylactic and allergic reactions

Lire plus
21 Oct 2011
publication

[An unexpected role for neutrophils in anaphylaxis]

Lire plus
01 Aug 2011
publication

A strain of Lactobacillus casei inhibits the effector phase of immune inflammation

Lire plus
23 Mar 2011
publication

Mouse and human neutrophils induce anaphylaxis

Lire plus
11 Feb 2011
publication

Cutting edge: intravenous Ig inhibits invariant NKT cell-mediated allergic airway inflammation through FcγRIIIA-dependent mechanisms

Lire plus
19 Jan 2011
publication

Cutting Edge: The murine high-affinity IgG receptor FcγRIV is sufficient for autoantibody-induced arthritis

Lire plus
20 Dec 2010
publication

Microbiota-induced tertiary lymphoid tissues aggravate inflammatory disease in the absence of RORgamma t and LTi cells

Lire plus
12 Feb 2010
publication

Differential recruitment of activating and inhibitory Fc gamma RII during phagocytosis

Lire plus
19 Oct 2009
publication

Ligand binding but undetected functional response of FcR after their capture by T cells via trogocytosis

Lire plus
18 Nov 2008
publication

Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses

Lire plus
23 Oct 2008
publication

FcgammaRIV is a mouse IgE receptor that resembles macrophage FcepsilonRI in humans and promotes IgE-induced lung inflammation

Lire plus
19 Dec 2005
publication

The SH2 domain-containing inositol 5-phosphatase SHIP1 is recruited to the intracytoplasmic domain of human FcgammaRIIB and is mandatory for negative regulation of B cell activation

Lire plus
07 Oct 2005
publication

Regulation of allergy by Fc receptors

Lire plus
01 Jul 2005
publication

FcgammaRIV: a novel FcR with distinct IgG subclass specificity

Lire plus
21 Jan 2005
publication

Platelet homeostasis is regulated by platelet expression of CD47 under normal conditions and in passive immune thrombocytopenia

Lire plus
28 Sep 2004
publication

Two distinct tyrosine-based motifs enable the inhibitory receptor FcgammaRIIB to cooperatively recruit the inositol phosphatases SHIP1/2 and the adapters Grb2/Grap

Lire plus
20 Nov 2003
publication

Intravenous immune globulin prevents venular vaso-occlusion in sickle cell mice by inhibiting leukocyte adhesion and the interactions between sickle erythrocytes and adherent leukocytes

Lire plus
01 Apr 2003
publication

Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease

Lire plus